Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes
ProjectD
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of the study is to examine the effect on metabolic parameters after 12 weeks of treatment with high dose vitamin D in patients with type 2 diabetes and vitamin D insufficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2 type-2-diabetes
Started Dec 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 19, 2008
CompletedFirst Posted
Study publicly available on registry
December 22, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedJuly 12, 2010
July 1, 2010
1.5 years
December 19, 2008
July 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insulin secretion and insulin resistance
6 hours
Secondary Outcomes (1)
Glycemic control, lipid status, inflammatory markers, BMD
2 months
Study Arms (2)
Cholecalciferol
ACTIVE COMPARATORPlacebo pill
PLACEBO COMPARATORInterventions
8 tablets equivalent to 280 micrograms for 2 weeks and 4 tablets equivalent to 140 micrograms for 10 weeks
Eligibility Criteria
You may qualify if:
- Informed consent
- Type 2 diabetes
- Patients of Danish extraction
- Vitamin D insufficiency (1,25OHvitD \< 50 nmol/l)
You may not qualify if:
- Nephropathy (Urea \> 12 mmol/l)
- S-calcium \> 2,52 mmol/L
- Primary hyperparathyroidism
- Serious disease
- Malabsorption
- Sarcoidosis
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Aarhus University Hospitalcollaborator
- Regionshospitalet Silkeborgcollaborator
Study Sites (1)
Medical Research Unit, Medical Department M, Aarhus University Hospital
Aarhus, 8000, Denmark
Related Publications (1)
Kampmann U, Mosekilde L, Juhl C, Moller N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. Metabolism. 2014 Sep;63(9):1115-24. doi: 10.1016/j.metabol.2014.06.008. Epub 2014 Jun 19.
PMID: 25044176DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lotte Oeskov, MD
Medical Department, Silkeborg Hospital, Falkevej 1-3, 8600 Silkeborg, Denmark
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 19, 2008
First Posted
December 22, 2008
Study Start
December 1, 2008
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
July 12, 2010
Record last verified: 2010-07